nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT1A1—Etoposide—germ cell cancer	0.086	0.131	CbGbCtD
Losartan—SLCO1B3—Methotrexate—germ cell cancer	0.0675	0.103	CbGbCtD
Losartan—CYP3A5—Ifosfamide—germ cell cancer	0.0548	0.0837	CbGbCtD
Losartan—CYP2C8—Ifosfamide—germ cell cancer	0.0527	0.0805	CbGbCtD
Losartan—CYP2C19—Ifosfamide—germ cell cancer	0.0442	0.0675	CbGbCtD
Losartan—SLCO1B1—Methotrexate—germ cell cancer	0.0393	0.0601	CbGbCtD
Losartan—CYP2C9—Ifosfamide—germ cell cancer	0.0368	0.0562	CbGbCtD
Losartan—ABCB1—Dactinomycin—germ cell cancer	0.0302	0.0462	CbGbCtD
Losartan—CYP3A5—Etoposide—germ cell cancer	0.0262	0.04	CbGbCtD
Losartan—SLC22A6—Methotrexate—germ cell cancer	0.0253	0.0386	CbGbCtD
Losartan—CYP2C8—Etoposide—germ cell cancer	0.0252	0.0385	CbGbCtD
Losartan—ALB—Methotrexate—germ cell cancer	0.0215	0.0329	CbGbCtD
Losartan—CYP3A4—Ifosfamide—germ cell cancer	0.0214	0.0327	CbGbCtD
Losartan—CYP1A2—Etoposide—germ cell cancer	0.0195	0.0298	CbGbCtD
Losartan—ABCB1—Vinblastine—germ cell cancer	0.0189	0.0289	CbGbCtD
Losartan—CYP2C9—Cisplatin—germ cell cancer	0.0179	0.0273	CbGbCtD
Losartan—ABCB1—Cisplatin—germ cell cancer	0.0174	0.0265	CbGbCtD
Losartan—ABCB1—Etoposide—germ cell cancer	0.017	0.026	CbGbCtD
Losartan—SLC2A9—Facilitative Na+-independent glucose transporters—SLC2A3—germ cell cancer	0.0144	0.145	CbGpPWpGaD
Losartan—SLC22A12—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.0114	0.114	CbGpPWpGaD
Losartan—CYP3A4—Vinblastine—germ cell cancer	0.0113	0.0173	CbGbCtD
Losartan—ABCB1—Methotrexate—germ cell cancer	0.0113	0.0172	CbGbCtD
Losartan—CYP3A4—Etoposide—germ cell cancer	0.0102	0.0156	CbGbCtD
Losartan—UGT2B17—Metapathway biotransformation—NAT9—germ cell cancer	0.00766	0.0769	CbGpPWpGaD
Losartan—CYP2C9—cardial valve—germ cell cancer	0.00737	0.0947	CbGeAlD
Losartan—UGT1A10—Metapathway biotransformation—NAT9—germ cell cancer	0.00473	0.0475	CbGpPWpGaD
Losartan—UGT1A1—urine—germ cell cancer	0.00378	0.0486	CbGeAlD
Losartan—UGT2B17—endocrine gland—germ cell cancer	0.00323	0.0415	CbGeAlD
Losartan—ACE—umbilical vein—germ cell cancer	0.00302	0.0388	CbGeAlD
Losartan—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00281	0.0282	CbGpPWpGaD
Losartan—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00275	0.0276	CbGpPWpGaD
Losartan—ACE—arm—germ cell cancer	0.00264	0.0339	CbGeAlD
Losartan—SLC2A9—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00253	0.0254	CbGpPWpGaD
Losartan—SLC2A9—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00249	0.025	CbGpPWpGaD
Losartan—ACE—urine—germ cell cancer	0.00244	0.0313	CbGeAlD
Losartan—ACE—appendage—germ cell cancer	0.00237	0.0305	CbGeAlD
Losartan—SLC22A12—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00231	0.0232	CbGpPWpGaD
Losartan—SLC22A12—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00228	0.0229	CbGpPWpGaD
Losartan—CYP2C19—urine—germ cell cancer	0.00205	0.0263	CbGeAlD
Losartan—SLCO1B3—Transport of organic anions—AVP—germ cell cancer	0.00204	0.0204	CbGpPWpGaD
Losartan—AGTR1—endothelium—germ cell cancer	0.00194	0.0249	CbGeAlD
Losartan—UGT1A3—Metapathway biotransformation—NAT9—germ cell cancer	0.00188	0.0189	CbGpPWpGaD
Losartan—ACE—Peptide hormone metabolism—INHA—germ cell cancer	0.00184	0.0185	CbGpPWpGaD
Losartan—SLC2A9—NRF2 pathway—SLC2A3—germ cell cancer	0.00182	0.0183	CbGpPWpGaD
Losartan—UGT1A10—endocrine gland—germ cell cancer	0.00182	0.0234	CbGeAlD
Losartan—AGTR1—blood vessel—germ cell cancer	0.00179	0.023	CbGeAlD
Losartan—CYP1A2—urine—germ cell cancer	0.00167	0.0215	CbGeAlD
Losartan—ACE—ganglion—germ cell cancer	0.00166	0.0213	CbGeAlD
Losartan—SLC2A9—adrenal gland—germ cell cancer	0.00165	0.0212	CbGeAlD
Losartan—ACE—Peptide hormone metabolism—KLF4—germ cell cancer	0.00164	0.0165	CbGpPWpGaD
Losartan—UGT2B7—Metapathway biotransformation—NAT9—germ cell cancer	0.0016	0.0161	CbGpPWpGaD
Losartan—CYP2C9—urine—germ cell cancer	0.00159	0.0204	CbGeAlD
Losartan—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00158	0.0158	CbGpPWpGaD
Losartan—SLC2A9—female gonad—germ cell cancer	0.00154	0.0197	CbGeAlD
Losartan—ACE—endothelium—germ cell cancer	0.00143	0.0184	CbGeAlD
Losartan—SLC2A9—endocrine gland—germ cell cancer	0.00143	0.0184	CbGeAlD
Losartan—SLCO1B1—Transport of organic anions—AVP—germ cell cancer	0.00137	0.0137	CbGpPWpGaD
Losartan—SLC2A9—testis—germ cell cancer	0.00136	0.0175	CbGeAlD
Losartan—ACE—blood vessel—germ cell cancer	0.00132	0.017	CbGeAlD
Losartan—UGT1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.0013	0.0131	CbGpPWpGaD
Losartan—UGT1A3—endocrine gland—germ cell cancer	0.00128	0.0165	CbGeAlD
Losartan—AGTR1—neck—germ cell cancer	0.00128	0.0164	CbGeAlD
Losartan—CYP3A4—urine—germ cell cancer	0.00121	0.0156	CbGeAlD
Losartan—SLCO1B3—pituitary gland—germ cell cancer	0.00116	0.015	CbGeAlD
Losartan—SLC2A9—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00115	0.0115	CbGpPWpGaD
Losartan—SLC2A9—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00113	0.0114	CbGpPWpGaD
Losartan—SLC22A12—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00105	0.0105	CbGpPWpGaD
Losartan—SLC22A12—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00104	0.0104	CbGpPWpGaD
Losartan—SLC2A9—lymph node—germ cell cancer	0.000987	0.0127	CbGeAlD
Losartan—ACE—neck—germ cell cancer	0.000945	0.0121	CbGeAlD
Losartan—SLCO1B3—endocrine gland—germ cell cancer	0.000902	0.0116	CbGeAlD
Losartan—SLC2A9—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000893	0.00896	CbGpPWpGaD
Losartan—AGTR1—decidua—germ cell cancer	0.000822	0.0106	CbGeAlD
Losartan—SLC22A12—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000817	0.00819	CbGpPWpGaD
Losartan—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000792	0.00794	CbGpPWpGaD
Losartan—ACE—embryo—germ cell cancer	0.000788	0.0101	CbGeAlD
Losartan—ALB—Transport of organic anions—AVP—germ cell cancer	0.000781	0.00784	CbGpPWpGaD
Losartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000755	0.00758	CbGpPWpGaD
Losartan—UGT2B7—endocrine gland—germ cell cancer	0.000737	0.00948	CbGeAlD
Losartan—AGTR1—pituitary gland—germ cell cancer	0.000706	0.00908	CbGeAlD
Losartan—UGT2B7—testis—germ cell cancer	0.000703	0.00904	CbGeAlD
Losartan—ACE—eye—germ cell cancer	0.000703	0.00903	CbGeAlD
Losartan—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000686	0.00688	CbGpPWpGaD
Losartan—AGTR1—medulla oblongata—germ cell cancer	0.000682	0.00876	CbGeAlD
Losartan—ACE—telencephalon—germ cell cancer	0.000641	0.00823	CbGeAlD
Losartan—AGTR1—adrenal gland—germ cell cancer	0.000631	0.00811	CbGeAlD
Losartan—UGT1A1—endocrine gland—germ cell cancer	0.000627	0.00806	CbGeAlD
Losartan—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	0.000612	0.00614	CbGpPWpGaD
Losartan—ACE—decidua—germ cell cancer	0.000607	0.0078	CbGeAlD
Losartan—UGT1A3—NRF2 pathway—SLC2A3—germ cell cancer	0.000592	0.00594	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000584	0.00586	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000575	0.00577	CbGpPWpGaD
Losartan—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000571	0.00573	CbGpPWpGaD
Losartan—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000563	0.00565	CbGpPWpGaD
Losartan—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000558	0.0056	CbGpPWpGaD
Losartan—AGTR1—endocrine gland—germ cell cancer	0.000547	0.00703	CbGeAlD
Losartan—AGTR1—head—germ cell cancer	0.00054	0.00694	CbGeAlD
Losartan—ACE—gonad—germ cell cancer	0.000535	0.00687	CbGeAlD
Losartan—SLC22A12—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000534	0.00536	CbGpPWpGaD
Losartan—SLC2A9—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00053	0.00532	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000526	0.00528	CbGpPWpGaD
Losartan—AGTR1—testis—germ cell cancer	0.000522	0.00671	CbGeAlD
Losartan—SLCO1B1—endocrine gland—germ cell cancer	0.000522	0.00671	CbGeAlD
Losartan—ACE—pituitary gland—germ cell cancer	0.000522	0.0067	CbGeAlD
Losartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000507	0.00509	CbGpPWpGaD
Losartan—UGT2B7—NRF2 pathway—SLC2A3—germ cell cancer	0.000503	0.00505	CbGpPWpGaD
Losartan—ALB—adrenal gland—germ cell cancer	0.000487	0.00626	CbGeAlD
Losartan—SLC22A12—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000485	0.00486	CbGpPWpGaD
Losartan—SLC22A6—brain—germ cell cancer	0.000484	0.00623	CbGeAlD
Losartan—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000477	0.00479	CbGpPWpGaD
Losartan—ACE—adrenal gland—germ cell cancer	0.000466	0.00599	CbGeAlD
Losartan—ABCB1—blood vessel—germ cell cancer	0.000465	0.00597	CbGeAlD
Losartan—ACE—bone marrow—germ cell cancer	0.000451	0.00579	CbGeAlD
Losartan—ACE—spinal cord—germ cell cancer	0.000449	0.00577	CbGeAlD
Losartan—ACE—female gonad—germ cell cancer	0.000434	0.00558	CbGeAlD
Losartan—UGT1A1—NRF2 pathway—SLC2A3—germ cell cancer	0.000409	0.0041	CbGpPWpGaD
Losartan—Agranulocytosis—Etoposide—germ cell cancer	0.000406	0.00242	CcSEcCtD
Losartan—Vision blurred—Ifosfamide—germ cell cancer	0.000406	0.00242	CcSEcCtD
Losartan—ACE—endocrine gland—germ cell cancer	0.000404	0.00519	CbGeAlD
Losartan—Thrombocytopenia—Bleomycin—germ cell cancer	0.000403	0.0024	CcSEcCtD
Losartan—ALB—testis—germ cell cancer	0.000403	0.00517	CbGeAlD
Losartan—Feeling abnormal—Vinblastine—germ cell cancer	0.000401	0.00239	CcSEcCtD
Losartan—Myalgia—Dactinomycin—germ cell cancer	0.0004	0.00238	CcSEcCtD
Losartan—Ill-defined disorder—Ifosfamide—germ cell cancer	0.0004	0.00238	CcSEcCtD
Losartan—ACE—head—germ cell cancer	0.000399	0.00513	CbGeAlD
Losartan—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000398	0.00237	CcSEcCtD
Losartan—Anaemia—Ifosfamide—germ cell cancer	0.000398	0.00237	CcSEcCtD
Losartan—Tinnitus—Cisplatin—germ cell cancer	0.000398	0.00237	CcSEcCtD
Losartan—Flushing—Cisplatin—germ cell cancer	0.000396	0.00236	CcSEcCtD
Losartan—Agitation—Ifosfamide—germ cell cancer	0.000396	0.00236	CcSEcCtD
Losartan—Discomfort—Dactinomycin—germ cell cancer	0.000395	0.00235	CcSEcCtD
Losartan—Angioedema—Ifosfamide—germ cell cancer	0.000394	0.00234	CcSEcCtD
Losartan—Anorexia—Bleomycin—germ cell cancer	0.000392	0.00233	CcSEcCtD
Losartan—AGTR1—brain—germ cell cancer	0.000392	0.00503	CbGeAlD
Losartan—Diabetes mellitus—Methotrexate—germ cell cancer	0.000389	0.00232	CcSEcCtD
Losartan—Hypoaesthesia—Etoposide—germ cell cancer	0.000389	0.00232	CcSEcCtD
Losartan—Malaise—Ifosfamide—germ cell cancer	0.000388	0.00231	CcSEcCtD
Losartan—Vertigo—Ifosfamide—germ cell cancer	0.000387	0.0023	CcSEcCtD
Losartan—Leukopenia—Ifosfamide—germ cell cancer	0.000386	0.0023	CcSEcCtD
Losartan—Photosensitivity—Methotrexate—germ cell cancer	0.000385	0.00229	CcSEcCtD
Losartan—ACE—testis—germ cell cancer	0.000385	0.00495	CbGeAlD
Losartan—Abdominal pain—Vinblastine—germ cell cancer	0.000385	0.00229	CcSEcCtD
Losartan—Hypotension—Bleomycin—germ cell cancer	0.000384	0.00229	CcSEcCtD
Losartan—Oedema—Dactinomycin—germ cell cancer	0.000384	0.00228	CcSEcCtD
Losartan—CYP2C8—pituitary gland—germ cell cancer	0.000383	0.00492	CbGeAlD
Losartan—Infection—Dactinomycin—germ cell cancer	0.000381	0.00227	CcSEcCtD
Losartan—Arrhythmia—Cisplatin—germ cell cancer	0.000381	0.00227	CcSEcCtD
Losartan—Palpitations—Ifosfamide—germ cell cancer	0.000381	0.00227	CcSEcCtD
Losartan—AGTR1—lymph node—germ cell cancer	0.000378	0.00486	CbGeAlD
Losartan—Alopecia—Cisplatin—germ cell cancer	0.000377	0.00224	CcSEcCtD
Losartan—Cough—Ifosfamide—germ cell cancer	0.000376	0.00224	CcSEcCtD
Losartan—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000376	0.00224	CcSEcCtD
Losartan—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000375	0.00223	CcSEcCtD
Losartan—Erythema—Cisplatin—germ cell cancer	0.000371	0.00221	CcSEcCtD
Losartan—Erythema multiforme—Etoposide—germ cell cancer	0.00037	0.0022	CcSEcCtD
Losartan—Paraesthesia—Bleomycin—germ cell cancer	0.000369	0.0022	CcSEcCtD
Losartan—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000368	0.00369	CbGpPWpGaD
Losartan—Dyspnoea—Bleomycin—germ cell cancer	0.000367	0.00218	CcSEcCtD
Losartan—Chest pain—Ifosfamide—germ cell cancer	0.000367	0.00218	CcSEcCtD
Losartan—Myalgia—Ifosfamide—germ cell cancer	0.000367	0.00218	CcSEcCtD
Losartan—Arthralgia—Ifosfamide—germ cell cancer	0.000367	0.00218	CcSEcCtD
Losartan—Flatulence—Cisplatin—germ cell cancer	0.000366	0.00218	CcSEcCtD
Losartan—Anorexia—Dactinomycin—germ cell cancer	0.000366	0.00218	CcSEcCtD
Losartan—Flushing—Etoposide—germ cell cancer	0.000363	0.00216	CcSEcCtD
Losartan—Discomfort—Ifosfamide—germ cell cancer	0.000362	0.00216	CcSEcCtD
Losartan—UGT2B17—Metabolism—SLC2A3—germ cell cancer	0.000361	0.00362	CbGpPWpGaD
Losartan—Hypersensitivity—Vinblastine—germ cell cancer	0.000359	0.00214	CcSEcCtD
Losartan—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000359	0.00214	CcSEcCtD
Losartan—Decreased appetite—Bleomycin—germ cell cancer	0.000358	0.00213	CcSEcCtD
Losartan—Muscle spasms—Cisplatin—germ cell cancer	0.000357	0.00213	CcSEcCtD
Losartan—UGT2B17—Metabolism—SLC22A3—germ cell cancer	0.000356	0.00357	CbGpPWpGaD
Losartan—Angiopathy—Etoposide—germ cell cancer	0.000355	0.00211	CcSEcCtD
Losartan—Confusional state—Ifosfamide—germ cell cancer	0.000355	0.00211	CcSEcCtD
Losartan—AGTR1—G alpha (q) signalling events—OXT—germ cell cancer	0.000353	0.00354	CbGpPWpGaD
Losartan—Pain—Bleomycin—germ cell cancer	0.000352	0.00209	CcSEcCtD
Losartan—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000352	0.00209	CcSEcCtD
Losartan—Oedema—Ifosfamide—germ cell cancer	0.000352	0.00209	CcSEcCtD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000352	0.00353	CbGpPWpGaD
Losartan—Vision blurred—Cisplatin—germ cell cancer	0.00035	0.00208	CcSEcCtD
Losartan—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00035	0.00208	CcSEcCtD
Losartan—Asthenia—Vinblastine—germ cell cancer	0.000349	0.00208	CcSEcCtD
Losartan—Infection—Ifosfamide—germ cell cancer	0.000349	0.00208	CcSEcCtD
Losartan—AGTR1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000348	0.0035	CbGpPWpGaD
Losartan—Tremor—Cisplatin—germ cell cancer	0.000348	0.00207	CcSEcCtD
Losartan—ACE—Metabolism of proteins—INHA—germ cell cancer	0.000347	0.00349	CbGpPWpGaD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000346	0.00347	CbGpPWpGaD
Losartan—Alopecia—Etoposide—germ cell cancer	0.000345	0.00206	CcSEcCtD
Losartan—Nervous system disorder—Ifosfamide—germ cell cancer	0.000345	0.00205	CcSEcCtD
Losartan—Ill-defined disorder—Cisplatin—germ cell cancer	0.000345	0.00205	CcSEcCtD
Losartan—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000344	0.00205	CcSEcCtD
Losartan—Anaemia—Cisplatin—germ cell cancer	0.000343	0.00204	CcSEcCtD
Losartan—CYP2C19—endocrine gland—germ cell cancer	0.00034	0.00437	CbGeAlD
Losartan—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00034	0.00202	CcSEcCtD
Losartan—Feeling abnormal—Bleomycin—germ cell cancer	0.000339	0.00202	CcSEcCtD
Losartan—ALB—Platelet degranulation—CD9—germ cell cancer	0.000336	0.00337	CbGpPWpGaD
Losartan—Anorexia—Ifosfamide—germ cell cancer	0.000335	0.002	CcSEcCtD
Losartan—Malaise—Cisplatin—germ cell cancer	0.000335	0.00199	CcSEcCtD
Losartan—Decreased appetite—Dactinomycin—germ cell cancer	0.000334	0.00199	CcSEcCtD
Losartan—Diarrhoea—Vinblastine—germ cell cancer	0.000333	0.00198	CcSEcCtD
Losartan—Dysgeusia—Etoposide—germ cell cancer	0.000333	0.00198	CcSEcCtD
Losartan—Leukopenia—Cisplatin—germ cell cancer	0.000332	0.00198	CcSEcCtD
Losartan—Fatigue—Dactinomycin—germ cell cancer	0.000331	0.00197	CcSEcCtD
Losartan—Back pain—Etoposide—germ cell cancer	0.000329	0.00196	CcSEcCtD
Losartan—Hypotension—Ifosfamide—germ cell cancer	0.000329	0.00196	CcSEcCtD
Losartan—Pain—Dactinomycin—germ cell cancer	0.000328	0.00195	CcSEcCtD
Losartan—Muscle spasms—Etoposide—germ cell cancer	0.000327	0.00195	CcSEcCtD
Losartan—Urticaria—Bleomycin—germ cell cancer	0.000327	0.00195	CcSEcCtD
Losartan—Body temperature increased—Bleomycin—germ cell cancer	0.000325	0.00194	CcSEcCtD
Losartan—Dizziness—Vinblastine—germ cell cancer	0.000322	0.00192	CcSEcCtD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.00032	0.00322	CbGpPWpGaD
Losartan—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00032	0.00191	CcSEcCtD
Losartan—Ataxia—Methotrexate—germ cell cancer	0.000318	0.00189	CcSEcCtD
Losartan—Myalgia—Cisplatin—germ cell cancer	0.000316	0.00188	CcSEcCtD
Losartan—Feeling abnormal—Dactinomycin—germ cell cancer	0.000316	0.00188	CcSEcCtD
Losartan—Paraesthesia—Ifosfamide—germ cell cancer	0.000316	0.00188	CcSEcCtD
Losartan—Ill-defined disorder—Etoposide—germ cell cancer	0.000316	0.00188	CcSEcCtD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000316	0.00317	CbGpPWpGaD
Losartan—Anxiety—Cisplatin—germ cell cancer	0.000315	0.00188	CcSEcCtD
Losartan—Anaemia—Etoposide—germ cell cancer	0.000314	0.00187	CcSEcCtD
Losartan—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000314	0.00187	CcSEcCtD
Losartan—Dyspnoea—Ifosfamide—germ cell cancer	0.000313	0.00187	CcSEcCtD
Losartan—Somnolence—Ifosfamide—germ cell cancer	0.000313	0.00186	CcSEcCtD
Losartan—Discomfort—Cisplatin—germ cell cancer	0.000312	0.00186	CcSEcCtD
Losartan—Vomiting—Vinblastine—germ cell cancer	0.00031	0.00184	CcSEcCtD
Losartan—ACE—Metabolism of proteins—KLF4—germ cell cancer	0.00031	0.00311	CbGpPWpGaD
Losartan—Malaise—Etoposide—germ cell cancer	0.000307	0.00183	CcSEcCtD
Losartan—Breast disorder—Methotrexate—germ cell cancer	0.000306	0.00182	CcSEcCtD
Losartan—Vertigo—Etoposide—germ cell cancer	0.000306	0.00182	CcSEcCtD
Losartan—Decreased appetite—Ifosfamide—germ cell cancer	0.000306	0.00182	CcSEcCtD
Losartan—Headache—Vinblastine—germ cell cancer	0.000305	0.00182	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000305	0.00181	CcSEcCtD
Losartan—Leukopenia—Etoposide—germ cell cancer	0.000305	0.00181	CcSEcCtD
Losartan—Body temperature increased—Dactinomycin—germ cell cancer	0.000303	0.00181	CcSEcCtD
Losartan—Abdominal pain—Dactinomycin—germ cell cancer	0.000303	0.00181	CcSEcCtD
Losartan—Fatigue—Ifosfamide—germ cell cancer	0.000303	0.0018	CcSEcCtD
Losartan—Oedema—Cisplatin—germ cell cancer	0.000303	0.0018	CcSEcCtD
Losartan—Anaphylactic shock—Cisplatin—germ cell cancer	0.000303	0.0018	CcSEcCtD
Losartan—Hypersensitivity—Bleomycin—germ cell cancer	0.000303	0.0018	CcSEcCtD
Losartan—ALB—brain—germ cell cancer	0.000302	0.00388	CbGeAlD
Losartan—Infection—Cisplatin—germ cell cancer	0.000301	0.00179	CcSEcCtD
Losartan—Constipation—Ifosfamide—germ cell cancer	0.000301	0.00179	CcSEcCtD
Losartan—Pain—Ifosfamide—germ cell cancer	0.000301	0.00179	CcSEcCtD
Losartan—Loss of consciousness—Etoposide—germ cell cancer	0.000299	0.00178	CcSEcCtD
Losartan—Nervous system disorder—Cisplatin—germ cell cancer	0.000297	0.00177	CcSEcCtD
Losartan—Cough—Etoposide—germ cell cancer	0.000297	0.00177	CcSEcCtD
Losartan—Thrombocytopenia—Cisplatin—germ cell cancer	0.000297	0.00177	CcSEcCtD
Losartan—CYP2C8—endocrine gland—germ cell cancer	0.000297	0.00381	CbGeAlD
Losartan—Tachycardia—Cisplatin—germ cell cancer	0.000296	0.00176	CcSEcCtD
Losartan—Asthenia—Bleomycin—germ cell cancer	0.000295	0.00176	CcSEcCtD
Losartan—Hyperhidrosis—Cisplatin—germ cell cancer	0.000293	0.00174	CcSEcCtD
Losartan—ALB—lymph node—germ cell cancer	0.000292	0.00375	CbGeAlD
Losartan—Pruritus—Bleomycin—germ cell cancer	0.000291	0.00173	CcSEcCtD
Losartan—UGT2B17—Metabolism—CRABP1—germ cell cancer	0.00029	0.00291	CbGpPWpGaD
Losartan—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00029	0.00291	CbGpPWpGaD
Losartan—Feeling abnormal—Ifosfamide—germ cell cancer	0.00029	0.00172	CcSEcCtD
Losartan—Chest pain—Etoposide—germ cell cancer	0.00029	0.00172	CcSEcCtD
Losartan—Eosinophilia—Methotrexate—germ cell cancer	0.00029	0.00172	CcSEcCtD
Losartan—Nausea—Vinblastine—germ cell cancer	0.000289	0.00172	CcSEcCtD
Losartan—ACE—brain—germ cell cancer	0.000289	0.00372	CbGeAlD
Losartan—Anorexia—Cisplatin—germ cell cancer	0.000289	0.00172	CcSEcCtD
Losartan—CYP3A5—female gonad—germ cell cancer	0.000288	0.0037	CbGeAlD
Losartan—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000288	0.00171	CcSEcCtD
Losartan—ABCB1—trigeminal ganglion—germ cell cancer	0.000287	0.00369	CbGeAlD
Losartan—Pancreatitis—Methotrexate—germ cell cancer	0.000287	0.00171	CcSEcCtD
Losartan—Discomfort—Etoposide—germ cell cancer	0.000286	0.0017	CcSEcCtD
Losartan—Hypotension—Cisplatin—germ cell cancer	0.000283	0.00169	CcSEcCtD
Losartan—CYP2C8—testis—germ cell cancer	0.000283	0.00364	CbGeAlD
Losartan—Hypersensitivity—Dactinomycin—germ cell cancer	0.000283	0.00168	CcSEcCtD
Losartan—Confusional state—Etoposide—germ cell cancer	0.00028	0.00167	CcSEcCtD
Losartan—ACE—lymph node—germ cell cancer	0.000279	0.00359	CbGeAlD
Losartan—Urticaria—Ifosfamide—germ cell cancer	0.000279	0.00166	CcSEcCtD
Losartan—Abdominal pain—Ifosfamide—germ cell cancer	0.000278	0.00165	CcSEcCtD
Losartan—Body temperature increased—Ifosfamide—germ cell cancer	0.000278	0.00165	CcSEcCtD
Losartan—Anaphylactic shock—Etoposide—germ cell cancer	0.000278	0.00165	CcSEcCtD
Losartan—CYP1A2—endocrine gland—germ cell cancer	0.000278	0.00357	CbGeAlD
Losartan—ABCB1—embryo—germ cell cancer	0.000277	0.00356	CbGeAlD
Losartan—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000276	0.00164	CcSEcCtD
Losartan—Infection—Etoposide—germ cell cancer	0.000276	0.00164	CcSEcCtD
Losartan—Asthenia—Dactinomycin—germ cell cancer	0.000275	0.00164	CcSEcCtD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000273	0.00274	CbGpPWpGaD
Losartan—Paraesthesia—Cisplatin—germ cell cancer	0.000272	0.00162	CcSEcCtD
Losartan—Thrombocytopenia—Etoposide—germ cell cancer	0.000272	0.00162	CcSEcCtD
Losartan—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000272	0.00162	CcSEcCtD
Losartan—Tachycardia—Etoposide—germ cell cancer	0.000271	0.00161	CcSEcCtD
Losartan—Dyspnoea—Cisplatin—germ cell cancer	0.00027	0.00161	CcSEcCtD
Losartan—Erectile dysfunction—Methotrexate—germ cell cancer	0.000269	0.0016	CcSEcCtD
Losartan—SLC2A9—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000269	0.0027	CbGpPWpGaD
Losartan—Hyperhidrosis—Etoposide—germ cell cancer	0.000268	0.0016	CcSEcCtD
Losartan—CYP3A5—endocrine gland—germ cell cancer	0.000268	0.00344	CbGeAlD
Losartan—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000267	0.00159	CcSEcCtD
Losartan—Anorexia—Etoposide—germ cell cancer	0.000265	0.00158	CcSEcCtD
Losartan—CYP2C9—endocrine gland—germ cell cancer	0.000264	0.00339	CbGeAlD
Losartan—Decreased appetite—Cisplatin—germ cell cancer	0.000263	0.00157	CcSEcCtD
Losartan—Diarrhoea—Dactinomycin—germ cell cancer	0.000263	0.00156	CcSEcCtD
Losartan—Pneumonia—Methotrexate—germ cell cancer	0.000262	0.00156	CcSEcCtD
Losartan—Vomiting—Bleomycin—germ cell cancer	0.000262	0.00156	CcSEcCtD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00026	0.0026	CbGpPWpGaD
Losartan—Hypotension—Etoposide—germ cell cancer	0.000259	0.00154	CcSEcCtD
Losartan—Rash—Bleomycin—germ cell cancer	0.000259	0.00154	CcSEcCtD
Losartan—Pain—Cisplatin—germ cell cancer	0.000259	0.00154	CcSEcCtD
Losartan—Dermatitis—Bleomycin—germ cell cancer	0.000259	0.00154	CcSEcCtD
Losartan—Hypersensitivity—Ifosfamide—germ cell cancer	0.000259	0.00154	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000259	0.00154	CcSEcCtD
Losartan—Renal failure—Methotrexate—germ cell cancer	0.000256	0.00153	CcSEcCtD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000256	0.00257	CbGpPWpGaD
Losartan—Conjunctivitis—Methotrexate—germ cell cancer	0.000254	0.00151	CcSEcCtD
Losartan—Asthenia—Ifosfamide—germ cell cancer	0.000252	0.0015	CcSEcCtD
Losartan—Sweating—Methotrexate—germ cell cancer	0.00025	0.00149	CcSEcCtD
Losartan—Feeling abnormal—Cisplatin—germ cell cancer	0.00025	0.00149	CcSEcCtD
Losartan—Paraesthesia—Etoposide—germ cell cancer	0.000249	0.00148	CcSEcCtD
Losartan—Pruritus—Ifosfamide—germ cell cancer	0.000249	0.00148	CcSEcCtD
Losartan—Dyspnoea—Etoposide—germ cell cancer	0.000248	0.00147	CcSEcCtD
Losartan—Somnolence—Etoposide—germ cell cancer	0.000247	0.00147	CcSEcCtD
Losartan—SLC22A12—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000246	0.00247	CbGpPWpGaD
Losartan—Epistaxis—Methotrexate—germ cell cancer	0.000246	0.00146	CcSEcCtD
Losartan—ABCB1—retina—germ cell cancer	0.000245	0.00315	CbGeAlD
Losartan—Nausea—Bleomycin—germ cell cancer	0.000244	0.00145	CcSEcCtD
Losartan—Vomiting—Dactinomycin—germ cell cancer	0.000244	0.00145	CcSEcCtD
Losartan—Agranulocytosis—Methotrexate—germ cell cancer	0.000243	0.00145	CcSEcCtD
Losartan—Rash—Dactinomycin—germ cell cancer	0.000242	0.00144	CcSEcCtD
Losartan—AGTR1—G alpha (q) signalling events—AVP—germ cell cancer	0.000242	0.00243	CbGpPWpGaD
Losartan—Decreased appetite—Etoposide—germ cell cancer	0.000241	0.00144	CcSEcCtD
Losartan—Diarrhoea—Ifosfamide—germ cell cancer	0.000241	0.00143	CcSEcCtD
Losartan—Body temperature increased—Cisplatin—germ cell cancer	0.00024	0.00143	CcSEcCtD
Losartan—Fatigue—Etoposide—germ cell cancer	0.000239	0.00143	CcSEcCtD
Losartan—AGTR1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000239	0.0024	CbGpPWpGaD
Losartan—Pain—Etoposide—germ cell cancer	0.000237	0.00141	CcSEcCtD
Losartan—Constipation—Etoposide—germ cell cancer	0.000237	0.00141	CcSEcCtD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000236	0.00237	CbGpPWpGaD
Losartan—Hepatitis—Methotrexate—germ cell cancer	0.000234	0.00139	CcSEcCtD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000234	0.00234	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000233	0.00233	CbGpPWpGaD
Losartan—Dizziness—Ifosfamide—germ cell cancer	0.000233	0.00138	CcSEcCtD
Losartan—Pharyngitis—Methotrexate—germ cell cancer	0.000232	0.00138	CcSEcCtD
Losartan—Feeling abnormal—Etoposide—germ cell cancer	0.000229	0.00136	CcSEcCtD
Losartan—Nausea—Dactinomycin—germ cell cancer	0.000228	0.00136	CcSEcCtD
Losartan—Gastrointestinal pain—Etoposide—germ cell cancer	0.000227	0.00135	CcSEcCtD
Losartan—ABCB1—telencephalon—germ cell cancer	0.000226	0.0029	CbGeAlD
Losartan—Vomiting—Ifosfamide—germ cell cancer	0.000224	0.00133	CcSEcCtD
Losartan—Hypersensitivity—Cisplatin—germ cell cancer	0.000223	0.00133	CcSEcCtD
Losartan—Rash—Ifosfamide—germ cell cancer	0.000222	0.00132	CcSEcCtD
Losartan—Dermatitis—Ifosfamide—germ cell cancer	0.000221	0.00132	CcSEcCtD
Losartan—Erythema multiforme—Methotrexate—germ cell cancer	0.000221	0.00132	CcSEcCtD
Losartan—Urticaria—Etoposide—germ cell cancer	0.000221	0.00131	CcSEcCtD
Losartan—Abdominal pain—Etoposide—germ cell cancer	0.00022	0.00131	CcSEcCtD
Losartan—Body temperature increased—Etoposide—germ cell cancer	0.00022	0.00131	CcSEcCtD
Losartan—Tinnitus—Methotrexate—germ cell cancer	0.000218	0.0013	CcSEcCtD
Losartan—Asthenia—Cisplatin—germ cell cancer	0.000217	0.00129	CcSEcCtD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000216	0.00217	CbGpPWpGaD
Losartan—ABCB1—decidua—germ cell cancer	0.000214	0.00275	CbGeAlD
Losartan—Angiopathy—Methotrexate—germ cell cancer	0.000212	0.00126	CcSEcCtD
Losartan—CYP2C8—brain—germ cell cancer	0.000212	0.00273	CbGeAlD
Losartan—Nausea—Ifosfamide—germ cell cancer	0.000209	0.00124	CcSEcCtD
Losartan—Diarrhoea—Cisplatin—germ cell cancer	0.000207	0.00123	CcSEcCtD
Losartan—Alopecia—Methotrexate—germ cell cancer	0.000207	0.00123	CcSEcCtD
Losartan—Hypersensitivity—Etoposide—germ cell cancer	0.000205	0.00122	CcSEcCtD
Losartan—Erythema—Methotrexate—germ cell cancer	0.000204	0.00121	CcSEcCtD
Losartan—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000202	0.00202	CbGpPWpGaD
Losartan—CYP3A4—endocrine gland—germ cell cancer	0.000201	0.00258	CbGeAlD
Losartan—Dysgeusia—Methotrexate—germ cell cancer	0.0002	0.00119	CcSEcCtD
Losartan—Asthenia—Etoposide—germ cell cancer	0.000199	0.00119	CcSEcCtD
Losartan—Back pain—Methotrexate—germ cell cancer	0.000197	0.00117	CcSEcCtD
Losartan—Pruritus—Etoposide—germ cell cancer	0.000196	0.00117	CcSEcCtD
Losartan—Vomiting—Cisplatin—germ cell cancer	0.000193	0.00115	CcSEcCtD
Losartan—Vision blurred—Methotrexate—germ cell cancer	0.000192	0.00114	CcSEcCtD
Losartan—Rash—Cisplatin—germ cell cancer	0.000191	0.00114	CcSEcCtD
Losartan—Dermatitis—Cisplatin—germ cell cancer	0.000191	0.00114	CcSEcCtD
Losartan—Diarrhoea—Etoposide—germ cell cancer	0.00019	0.00113	CcSEcCtD
Losartan—Ill-defined disorder—Methotrexate—germ cell cancer	0.000189	0.00113	CcSEcCtD
Losartan—Anaemia—Methotrexate—germ cell cancer	0.000188	0.00112	CcSEcCtD
Losartan—ABCB1—gonad—germ cell cancer	0.000188	0.00242	CbGeAlD
Losartan—ABCB1—uterus—germ cell cancer	0.000187	0.0024	CbGeAlD
Losartan—Malaise—Methotrexate—germ cell cancer	0.000184	0.00109	CcSEcCtD
Losartan—Dizziness—Etoposide—germ cell cancer	0.000184	0.00109	CcSEcCtD
Losartan—ABCB1—pituitary gland—germ cell cancer	0.000184	0.00236	CbGeAlD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000183	0.00184	CbGpPWpGaD
Losartan—Vertigo—Methotrexate—germ cell cancer	0.000183	0.00109	CcSEcCtD
Losartan—Leukopenia—Methotrexate—germ cell cancer	0.000182	0.00109	CcSEcCtD
Losartan—Nausea—Cisplatin—germ cell cancer	0.00018	0.00107	CcSEcCtD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000179	0.00179	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—OXT—germ cell cancer	0.000178	0.00179	CbGpPWpGaD
Losartan—Cough—Methotrexate—germ cell cancer	0.000178	0.00106	CcSEcCtD
Losartan—ABCB1—medulla oblongata—germ cell cancer	0.000177	0.00228	CbGeAlD
Losartan—Vomiting—Etoposide—germ cell cancer	0.000177	0.00105	CcSEcCtD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000176	0.00177	CbGpPWpGaD
Losartan—Rash—Etoposide—germ cell cancer	0.000175	0.00104	CcSEcCtD
Losartan—Dermatitis—Etoposide—germ cell cancer	0.000175	0.00104	CcSEcCtD
Losartan—Headache—Etoposide—germ cell cancer	0.000174	0.00104	CcSEcCtD
Losartan—Arthralgia—Methotrexate—germ cell cancer	0.000174	0.00103	CcSEcCtD
Losartan—Chest pain—Methotrexate—germ cell cancer	0.000174	0.00103	CcSEcCtD
Losartan—Myalgia—Methotrexate—germ cell cancer	0.000174	0.00103	CcSEcCtD
Losartan—Discomfort—Methotrexate—germ cell cancer	0.000171	0.00102	CcSEcCtD
Losartan—Confusional state—Methotrexate—germ cell cancer	0.000168	0.000998	CcSEcCtD
Losartan—Anaphylactic shock—Methotrexate—germ cell cancer	0.000166	0.00099	CcSEcCtD
Losartan—Infection—Methotrexate—germ cell cancer	0.000165	0.000984	CcSEcCtD
Losartan—Nausea—Etoposide—germ cell cancer	0.000165	0.000982	CcSEcCtD
Losartan—ABCB1—adrenal gland—germ cell cancer	0.000164	0.00211	CbGeAlD
Losartan—Nervous system disorder—Methotrexate—germ cell cancer	0.000163	0.000971	CcSEcCtD
Losartan—Thrombocytopenia—Methotrexate—germ cell cancer	0.000163	0.00097	CcSEcCtD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000162	0.00163	CbGpPWpGaD
Losartan—ABCB1—midbrain—germ cell cancer	0.000162	0.00208	CbGeAlD
Losartan—Hyperhidrosis—Methotrexate—germ cell cancer	0.000161	0.000957	CcSEcCtD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00016	0.00161	CbGpPWpGaD
Losartan—ABCB1—bone marrow—germ cell cancer	0.000159	0.00204	CbGeAlD
Losartan—Anorexia—Methotrexate—germ cell cancer	0.000159	0.000944	CcSEcCtD
Losartan—ABCB1—spinal cord—germ cell cancer	0.000158	0.00203	CbGeAlD
Losartan—Hypotension—Methotrexate—germ cell cancer	0.000155	0.000925	CcSEcCtD
Losartan—ABCB1—female gonad—germ cell cancer	0.000153	0.00197	CbGeAlD
Losartan—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000152	0.000902	CcSEcCtD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000151	0.00151	CbGpPWpGaD
Losartan—Insomnia—Methotrexate—germ cell cancer	0.00015	0.000896	CcSEcCtD
Losartan—Paraesthesia—Methotrexate—germ cell cancer	0.000149	0.000889	CcSEcCtD
Losartan—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000149	0.0015	CbGpPWpGaD
Losartan—Dyspnoea—Methotrexate—germ cell cancer	0.000148	0.000883	CcSEcCtD
Losartan—Somnolence—Methotrexate—germ cell cancer	0.000148	0.00088	CcSEcCtD
Losartan—Dyspepsia—Methotrexate—germ cell cancer	0.000146	0.000872	CcSEcCtD
Losartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000145	0.00145	CbGpPWpGaD
Losartan—Decreased appetite—Methotrexate—germ cell cancer	0.000145	0.000861	CcSEcCtD
Losartan—Fatigue—Methotrexate—germ cell cancer	0.000143	0.000854	CcSEcCtD
Losartan—ABCB1—endocrine gland—germ cell cancer	0.000142	0.00183	CbGeAlD
Losartan—Pain—Methotrexate—germ cell cancer	0.000142	0.000847	CcSEcCtD
Losartan—ABCB1—head—germ cell cancer	0.00014	0.0018	CbGeAlD
Losartan—Feeling abnormal—Methotrexate—germ cell cancer	0.000137	0.000816	CcSEcCtD
Losartan—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000136	0.00081	CcSEcCtD
Losartan—ABCB1—testis—germ cell cancer	0.000136	0.00174	CbGeAlD
Losartan—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000135	0.00135	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000133	0.00133	CbGpPWpGaD
Losartan—Urticaria—Methotrexate—germ cell cancer	0.000132	0.000787	CcSEcCtD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000132	0.00132	CbGpPWpGaD
Losartan—Body temperature increased—Methotrexate—germ cell cancer	0.000131	0.000783	CcSEcCtD
Losartan—Abdominal pain—Methotrexate—germ cell cancer	0.000131	0.000783	CcSEcCtD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00013	0.0013	CbGpPWpGaD
Losartan—ABCB1—cerebellum—germ cell cancer	0.000125	0.00161	CbGeAlD
Losartan—Hypersensitivity—Methotrexate—germ cell cancer	0.000123	0.00073	CcSEcCtD
Losartan—AGTR1—GPCR ligand binding—AVP—germ cell cancer	0.000122	0.00122	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.00012	0.0012	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00012	0.0012	CbGpPWpGaD
Losartan—Asthenia—Methotrexate—germ cell cancer	0.000119	0.00071	CcSEcCtD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000118	0.00119	CbGpPWpGaD
Losartan—Pruritus—Methotrexate—germ cell cancer	0.000118	0.000701	CcSEcCtD
Losartan—Diarrhoea—Methotrexate—germ cell cancer	0.000114	0.000678	CcSEcCtD
Losartan—Dizziness—Methotrexate—germ cell cancer	0.00011	0.000655	CcSEcCtD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000109	0.00109	CbGpPWpGaD
Losartan—Vomiting—Methotrexate—germ cell cancer	0.000106	0.00063	CcSEcCtD
Losartan—Rash—Methotrexate—germ cell cancer	0.000105	0.000624	CcSEcCtD
Losartan—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000105	0.00105	CbGpPWpGaD
Losartan—Dermatitis—Methotrexate—germ cell cancer	0.000105	0.000624	CcSEcCtD
Losartan—Headache—Methotrexate—germ cell cancer	0.000104	0.00062	CcSEcCtD
Losartan—ABCB1—brain—germ cell cancer	0.000102	0.00131	CbGeAlD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000101	0.00102	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—OXT—germ cell cancer	0.000101	0.00101	CbGpPWpGaD
Losartan—Nausea—Methotrexate—germ cell cancer	9.88e-05	0.000588	CcSEcCtD
Losartan—ABCB1—lymph node—germ cell cancer	9.83e-05	0.00126	CbGeAlD
Losartan—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.18e-05	0.000922	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—OXT—germ cell cancer	9.13e-05	0.000916	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SLC2A3—germ cell cancer	8.88e-05	0.000891	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SLC22A3—germ cell cancer	8.75e-05	0.000878	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SLC2A3—germ cell cancer	8.37e-05	0.00084	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SLC22A3—germ cell cancer	8.24e-05	0.000827	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—AVP—germ cell cancer	8.24e-05	0.000827	CbGpPWpGaD
Losartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	7.96e-05	0.000799	CbGpPWpGaD
Losartan—ALB—Hemostasis—CD9—germ cell cancer	7.69e-05	0.000772	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SLC2A3—germ cell cancer	7.55e-05	0.000757	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SLC22A3—germ cell cancer	7.44e-05	0.000746	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CRABP1—germ cell cancer	7.13e-05	0.000715	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AVP—germ cell cancer	6.89e-05	0.000692	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.86e-05	0.000688	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.75e-05	0.000678	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CRABP1—germ cell cancer	6.72e-05	0.000674	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	6.68e-05	0.000671	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	6.53e-05	0.000655	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AVP—germ cell cancer	6.26e-05	0.000628	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.22e-05	0.000624	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SLC2A3—germ cell cancer	6.13e-05	0.000616	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	6.08e-05	0.00061	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CRABP1—germ cell cancer	6.06e-05	0.000608	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SLC22A3—germ cell cancer	6.04e-05	0.000606	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.01e-05	0.000603	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.92e-05	0.000594	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TP53—germ cell cancer	5.88e-05	0.00059	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.82e-05	0.000584	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.79e-05	0.000581	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SLC2A3—germ cell cancer	5.62e-05	0.000564	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SLC22A3—germ cell cancer	5.54e-05	0.000556	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.54e-05	0.000555	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—OXT—germ cell cancer	5.39e-05	0.000541	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	5.25e-05	0.000527	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.2e-05	0.000522	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CRABP1—germ cell cancer	4.93e-05	0.000494	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.74e-05	0.000476	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FGF4—germ cell cancer	4.6e-05	0.000462	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CRABP1—germ cell cancer	4.51e-05	0.000453	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—H2AFZ—germ cell cancer	4.11e-05	0.000413	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.05e-05	0.000406	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KITLG—germ cell cancer	3.78e-05	0.00038	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC2A3—germ cell cancer	3.73e-05	0.000374	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AVP—germ cell cancer	3.7e-05	0.000371	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC22A3—germ cell cancer	3.67e-05	0.000369	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC2A3—germ cell cancer	3.23e-05	0.000324	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC2A3—germ cell cancer	3.21e-05	0.000322	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC22A3—germ cell cancer	3.18e-05	0.000319	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC22A3—germ cell cancer	3.16e-05	0.000317	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	3.16e-05	0.000317	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CRABP1—germ cell cancer	2.99e-05	0.0003	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC2A3—germ cell cancer	2.88e-05	0.000289	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC22A3—germ cell cancer	2.84e-05	0.000285	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.81e-05	0.000282	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FGFR3—germ cell cancer	2.81e-05	0.000282	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.77e-05	0.000278	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.77e-05	0.000278	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.68e-05	0.000269	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC2A3—germ cell cancer	2.63e-05	0.000264	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CRABP1—germ cell cancer	2.59e-05	0.00026	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC22A3—germ cell cancer	2.59e-05	0.00026	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KIT—germ cell cancer	2.58e-05	0.000259	CbGpPWpGaD
Losartan—ALB—Metabolism—CRABP1—germ cell cancer	2.58e-05	0.000259	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CRABP1—germ cell cancer	2.32e-05	0.000232	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CRABP1—germ cell cancer	2.26e-05	0.000227	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC2A3—germ cell cancer	2.25e-05	0.000225	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC22A3—germ cell cancer	2.21e-05	0.000222	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.2e-05	0.000221	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CRABP1—germ cell cancer	2.11e-05	0.000212	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—germ cell cancer	1.89e-05	0.000189	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CRABP1—germ cell cancer	1.8e-05	0.000181	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.73e-05	0.000174	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.71e-05	0.000171	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—germ cell cancer	1.42e-05	0.000143	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.39e-05	0.00014	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—germ cell cancer	1.17e-05	0.000117	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—germ cell cancer	1.15e-05	0.000116	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—germ cell cancer	1.12e-05	0.000112	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—germ cell cancer	1.1e-05	0.000111	CbGpPWpGaD
